Urologix, Inc. (ULGX)
F3Q2012 Results Earnings Call
April 26, 2012 5:00 PM ET
Stryker Warren, Jr. – Chief Executive Officer
Brian Smrdel – Chief Financial Officer
Greg Fluet – Executive Vice President and COO
Jeff Adams – Private Investor
Deepak Chaulagai – Dougherty & Company
Larry Haimovitch – HMTC
Good day, ladies and gentlemen. And welcome to the Urologix Incorporated Fiscal Year 2012 Third Quarter Conference Call. My name is Bill, and I will be your coordinator for today. At this time, all participants are in listen-only mode. We will be facilitating a question-and-answer session towards the end of the conference. As a reminder, this conference is being recorded for replay purposes.
Certain information discussed during this conference call, including answers to your questions, may contain forward-looking statements that are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995.
Actual results may differ materially from those stated or implied in any forward-looking statements due to risks and uncertainties. A detailed discussion of risks and uncertainties maybe found in Urologix’s recent report on Form 10-K for the year ended June 30, 2011, and other documents filed with the Securities and Exchange Commission. Urologix disclaims any obligation to update any forward-looking statements made during the course of this call.
At this time, I will turn over the call to Mr. Stryker Warren, Jr., Chief Executive Officer. Please proceed, sir.